Health Care: Drugs

Novavax Inc (NVAX: NASDAQ)

$4.27 n/a | n/a%
08/01/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 4.27
52 Week High 6.95
52 Week Low 2.24
Avg. Daily Vol. (Mil) 3.92
Beta (3 year) 1.04
Share Related Items
Mkt Cap (Mil) 1,016.50
Shares Out (Mil) 238.06
Float (Mil) 173.45
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 9.00
Current Ratio 9.40
LT Debt/ Equity 0.01
Total Debt / Equity 0.01
Valuation Ratios
Price Earnings n.a.
Price/Sales 41.42
Price/Book 5.32
Price/Cash Flow -19.50
Per Share Data
Earnings -0.30
Sales 0.10
Book Value 0.80
Cash Flow -0.22
Business Summary
Novavax, Inc. is a clinical-stage biopharmaceutical company engaged in creating differentiated, value- upon current preventive options for various infectious diseases.
General Information
20 Firstfield Road
Garthersburg, MD 20878
www.novavax.com
Industry : Drugs
Sector: Health Care
Employees: 213
CEO: Stanley C. Erck
Short Interest
Current Month (Mil) 26.92
Previous Month (Mil) 24.26
Short Interest Ratio (Days) 7.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -25.50
Return on Investments -29.00
Profitability
Gross Margin 76.00
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NVAX

Latest NVAX Headlines from TheStreet

More Financial News for NVAX

Press Releases for NVAX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter